Q-Tee Fungi Bio-Products Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -531.69%
- Ebitda -35057.14%
- Net Worth -36.21%
- Total Assets -27.46%
About Q-Tee Fungi Bio-Products
Q-Tee Fungi Bio-Products Private Limited (QFBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 07 November 2020 (Four years and two months 26 days old ). Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Janayash Desai and Dhara Patel serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U15134GJ2020PTC118069
-
Company No.
118069
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Nov 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Q-Tee Fungi Bio-Products?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Janayash Desai
|
Director | 07-Nov-2020 | Current |
|
Dhara Patel
|
Director | 07-Nov-2020 | Current |
Financial Performance of Q-Tee Fungi Bio-Products.
Q-Tee Fungi Bio-Products Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 531.69% decrease in profit. The company's net worth observed a substantial decline by a decrease of 36.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Q-Tee Fungi Bio-Products?
Unlock access to Q-Tee Fungi Bio-Products's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Saptarishi Agro Industries LimitedJanayash Desai is a mutual person
-
Queen's Fungiworld Bio-Tech Private LimitedJanayash Desai and Dhara Patel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Q-Tee Fungi Bio-Products?
Q-Tee Fungi Bio-Products has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Q-Tee Fungi Bio-Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Q-Tee Fungi Bio-Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.